YGR127W is a protein-coding gene in Saccharomyces cerevisiae (budding yeast). It encodes a protein linked to lipid homeostasis and mitochondrial function, with orthologs in humans (TANGO2) and other eukaryotes . The term "YGR127W antibody" refers to immunological reagents specifically targeting this protein for research applications.
Key structural and functional properties of the YGR127W protein are summarized below:
| Property | Value |
|---|---|
| Molecular Weight | ~22 kDa (predicted) |
| Isoelectric Point (pI) | 6.7 |
| Amino Acid Length | 196 residues |
| Domains | Mitochondrial localization signals |
| Post-Translational Modifications | Phosphorylation sites identified |
Source: Saccharomyces Genome Database (SGD) .
YGR127W antibodies are primarily used to study the protein’s role in lipid droplet (LD) dynamics and mitochondrial-ER interactions. Key findings include:
Lipid Homeostasis: Knockdown of TANGO2 (human ortholog) increases LD size and alters phosphatidic acid (PA) levels, suggesting YGR127W’s role in lipid metabolism .
Mitochondrial Localization: Live-cell imaging confirmed YGR127W/TANGO2 localization at mitochondria-ER-LD junctions, critical for lipid trafficking .
Antibody Validation: Anti-TANGO2 antibodies (cross-reactive with YGR127W in yeast) have been used to track protein dynamics via FRET microscopy .
While no commercial YGR127W-specific antibody is explicitly documented, studies on its orthologs highlight:
Epitope Design: Antibodies targeting disease-associated mutants (e.g., lamin A/C) emphasize the importance of epitope context for specificity .
Yeast Engineering: S. cerevisiae strains engineered for enhanced antibody secretion (e.g., via IRE1 and PSA1 co-expression) provide frameworks for producing recombinant antibodies .
Studies on human TANGO2 reveal parallels with YGR127W:
Lipid Imbalances: TANGO2-deficient cells show elevated lysophosphatidic acid (LPA) and reduced cardiolipin, implicating YGR127W in acyl-CoA metabolism .
Reactive Oxygen Species (ROS): Loss of TANGO2 increases ROS, suggesting a conserved role in oxidative stress mitigation .
YGR127W is a protein encoded by the Saccharomyces cerevisiae genome, specifically from strain ATCC 204508/S288c (baker's yeast). The protein is identified by UniProt accession number P53275 . YGR127W antibodies are significant for researchers studying yeast molecular biology, cellular processes, and protein function. These antibodies enable detection, quantification, and localization of the target protein in various experimental contexts, contributing to our understanding of yeast biology and potentially conserved cellular mechanisms across eukaryotes.
YGR127W antibodies are valuable tools for multiple research applications including Western blotting, immunoprecipitation, immunohistochemistry, and immunofluorescence. These applications allow researchers to detect the protein's expression levels, examine protein-protein interactions, visualize cellular localization, and investigate functional changes under various experimental conditions. Particularly in yeast genetics and molecular biology research, these antibodies enable tracking of native proteins or tagged variants to understand cellular processes and regulatory mechanisms .
Proper validation of YGR127W antibodies is essential for generating reliable research data. Methodological validation should include:
Specificity testing using positive and negative controls (wild-type vs. YGR127W knockout yeast strains)
Concentration optimization through titration experiments
Cross-reactivity assessment against similar yeast proteins
Verification across multiple experimental techniques (Western blot, immunoprecipitation)
Reproducibility confirmation with alternative antibody clones or epitopes
Additionally, validating the antibody's performance under your specific experimental conditions is crucial, as factors like fixation methods, buffer compositions, and incubation parameters can significantly impact results .
Yeast surface display (YSD) combined with YGR127W antibodies presents sophisticated research possibilities. Researchers can employ Autonomous Hypermutation yEast surfAce Display (AHEAD) technology, which pairs orthogonal DNA replication with YSD to achieve rapid evolution of antibodies. In this system, yeast cells self-diversify their displayed antibodies, enabling autonomous exploration of sequence space .
For YGR127W-specific applications, methodological approaches include:
Encoding YGR127W-recognizing antibody fragments on p1 plasmids in engineered yeast
Displaying these fragments as fusions to Aga2p mating adhesion receptors on the cell surface
Subjecting populations to fluorescence-activated cell sorting (FACS) for binding optimization
Continuous mutation and selection to improve affinity and specificity
This technique has demonstrated up to 925-fold improvements in binding affinities through sequential fixation of multiple mutations over several cycles .
When investigating YGR127W's interactions with other proteins, several methodological refinements should be implemented:
Choose appropriate co-immunoprecipitation buffers that preserve native protein complexes
Consider proximity labeling techniques (BioID or APEX) to capture transient interactions
Implement crosslinking strategies to stabilize weak or transient interactions
Use reciprocal co-IP approaches with antibodies targeting suspected interaction partners
Validate interactions with orthogonal methods (yeast two-hybrid, FRET, or BiFC)
Researchers should be particularly attentive to experimental conditions that might disrupt physiological interactions, including detergent concentration, salt levels, and pH. Additionally, antibody epitope accessibility may change when YGR127W is engaged in protein complexes, potentially requiring multiple antibodies targeting different regions of the protein .
Leveraging glycoengineered Saccharomyces cerevisiae strains offers sophisticated approaches to enhance YGR127W antibody functionality. Researchers can develop specialized yeast expression systems that modify N-glycan structures on antibodies using the following methodological framework:
Generate yeast strains expressing endoglycosidases like EndoS2 that cleave N-glycans with specificity
Integrate the expression construct into the yeast genome at the LEU2 site using Yeast Integrating Plasmid (YIP)
Transform cells with appropriate display plasmids (like pYD1-IgG1 Fc) for antibody expression
Validate successful integration and expression through PCR-based colony screening
Optimize glycan profiles for enhanced binding properties and stability
These glycoengineered antibody systems can provide more homogeneous glycan profiles, potentially increasing reproducibility and functional characteristics of YGR127W antibodies in research applications .
Robust experimental design with appropriate controls is essential for generating reliable data with YGR127W antibodies. Implement the following methodological approaches:
Include YGR127W knockout/deletion strains as negative controls
Use purified recombinant YGR127W protein as a positive control
Implement isotype-matched irrelevant antibodies to control for non-specific binding
Include blocking peptide controls to verify epitope specificity
Prepare secondary antibody-only controls to assess background signal
Advanced designs should also incorporate genomically tagged YGR127W variants (with GFP, FLAG, or HA) that can be detected with alternative well-characterized antibodies, providing independent verification of results .
For effective immunolocalization of YGR127W in yeast cells, optimize the following methodological parameters:
Fixation protocols:
Test paraformaldehyde (3-4%) vs. methanol fixation to determine optimal epitope preservation
Consider dual fixation with formaldehyde followed by methanol for certain applications
Optimize fixation time (15-30 minutes) to balance cell morphology and antibody accessibility
Cell wall digestion:
Implement zymolyase or lyticase treatment (optimize concentration and duration)
Monitor spheroplast formation microscopically to ensure adequate cell wall digestion
Include osmotic stabilizers (1.2M sorbitol) in buffers to maintain cell integrity
Permeabilization methods:
Test graduated concentrations of detergents (0.1-0.5% Triton X-100 or 0.05-0.2% SDS)
Optimize permeabilization time to balance antibody accessibility and protein retention
Consider temperature variations during permeabilization (4°C vs. room temperature)
Each of these parameters should be systematically tested and optimized for specific experimental objectives, as YGR127W localization patterns may be sensitive to procedural variations .
When encountering signal problems with YGR127W antibodies, implement this systematic troubleshooting framework:
For weak or absent signals:
Verify antibody activity through dot blot or Western blot of purified YGR127W
Increase antibody concentration through careful titration experiments
Extend primary antibody incubation time or temperature modifications
Test alternative epitope exposure methods (heat-induced, pressure cooker, or microwave-based)
Evaluate different detection systems (enhanced chemiluminescence vs. fluorescent secondary antibodies)
For high background:
Increase blocking stringency (5% BSA or 5% milk, overnight at 4°C)
Implement additional wash steps with increased detergent concentration (0.1-0.3% Tween-20)
Pre-adsorb antibodies against fixed negative control cells
Reduce secondary antibody concentration
Include protein-free blocking reagents to reduce hydrophobic interactions
Methodical documentation of each modification is essential for optimizing protocols for specific applications .
Robust quantification of YGR127W protein levels requires systematic analytical approaches:
Western blot quantification:
Implement standard curves using purified recombinant YGR127W
Normalize to multiple housekeeping proteins (e.g., actin, GAPDH)
Use digital imaging systems with validated linear dynamic range
Apply rolling ball background subtraction algorithms
Analyze technical and biological replicates for statistical validation
Flow cytometry analysis:
Establish fluorescence intensity gates based on negative controls
Use median fluorescence intensity (MFI) rather than mean values
Apply compensation matrices for multi-color experiments
Analyze minimum of 10,000 events per sample for statistical reliability
Implement standardized beads for day-to-day calibration
Image-based quantification:
Use automated image analysis algorithms for unbiased quantification
Implement watershed segmentation for closely packed yeast cells
Analyze Z-stack images for complete cellular representation
Apply deconvolution algorithms to improve signal-to-noise ratio
Normalize to cell volume or area for accurate comparisons
Each quantification method should be validated across multiple experimental conditions to ensure reliability and reproducibility .
When facing contradictory results between YGR127W antibody data and other experimental approaches, implement this methodological framework:
Technical validation:
Test multiple antibody clones targeting different YGR127W epitopes
Verify antibody specificity using genetic knockouts or knockdowns
Implement orthogonal detection methods (mass spectrometry-based identification)
Assess potential post-translational modifications that might affect epitope recognition
Biological considerations:
Evaluate whether contradictions reflect biological reality (e.g., differences between protein abundance and activity)
Consider temporal dynamics and potential rapid protein turnover
Assess subcellular compartmentalization that might affect detection efficiency
Examine strain-specific genetic variations that could alter epitope sequences
Integrated analysis approach:
Implement triangulation with multiple independent methods
Conduct dose-response or time-course experiments to identify pattern discrepancies
Use computational modeling to generate testable hypotheses explaining contradictions
Design critical experiments specifically targeting the source of contradictions
This systematic approach transforms contradictory results from obstacles into opportunities for deeper biological insights .
Adapting YGR127W antibodies for high-throughput screening requires sophisticated methodological adaptations:
Antibody microarray implementation:
Optimize spotting buffer composition to maintain antibody functionality
Determine optimal surface chemistry for maximal antibody activity
Establish signal-to-background thresholds based on control samples
Develop computational pipelines for automated signal quantification
Implement quality control metrics for spot morphology and intensity
Automated immunofluorescence protocols:
Adapt fixation and staining for 96/384-well formats
Optimize antibody concentration to minimize consumption
Implement robotic liquid handling systems with validated protocols
Develop machine learning algorithms for image analysis and phenotype classification
Validate with spike-in controls across plates for inter-plate normalization
Flow cytometry adaptation:
Establish protocols for small-volume automated sampling
Optimize staining in multiwell formats with minimized antibody consumption
Implement fluorescent barcoding for multiplexed sample analysis
Develop automated gating strategies based on control populations
Create quality control metrics for consistent analysis across batches
Each of these methodological adaptations requires systematic optimization and validation for reliable high-throughput applications .
For single-cell analysis of YGR127W in heterogeneous populations, implement these advanced methodological approaches:
Single-cell immunofluorescence methods:
Apply microfluidic cell capture devices for consistent processing
Implement quantitative image cytometry with cell segmentation algorithms
Utilize confocal microscopy with high numerical aperture objectives
Develop computational pipelines for automated identification of subcellular compartments
Correlate protein localization with morphological features
Mass cytometry approaches:
Conjugate YGR127W antibodies with rare earth metals for CyTOF analysis
Develop multiplexed antibody panels for comprehensive protein network analysis
Implement viSNE or SPADE algorithms for high-dimensional data visualization
Apply pseudotime analysis for developmental trajectory reconstruction
Correlate YGR127W expression with cell cycle markers
In situ analysis techniques:
Adapt proximity ligation assays for visualization of YGR127W protein interactions
Implement multiplexed ion beam imaging (MIBI) for high-parameter spatial analysis
Develop RNA-protein co-detection methods to correlate transcript and protein levels
Apply computational spatial analysis to identify microenvironmental influences
Integrate with metabolic profiling for functional correlation
These techniques enable unprecedented insights into the heterogeneity of YGR127W expression and function at single-cell resolution .